China Pharmaceuticals and Healthcare Report - Q4 2014

Business Monitor International
September 10, 2014
197 Pages - SKU: BMI5325553
Countries covered: China

China Pharmaceuticals and Healthcare Report - Q4 2014

BMI View: A more 'rational' use of pharmaceuticals through pharmacoeconomics, and a crackdown onillegal rebates and corruption in China's pharmaceutical market could hinder the sector's growth potential.

However, over the long term, the government is likely to improve its investment in healthcare in order toretain public support.

Headline Expenditure Projections

Pharmaceuticals: CNY532.4bn (US$86.6bn) in 2013 to CNY616.1bn (US$99.3bn) in 2014; +15.7% inlocal currency and +14.7% in US dollar terms. Forecast broadly unchanged from Q313.

Healthcare: CNY3,230.8bn (US$525.4bn) in 2013 to CNY3,692.0bn (US$595.2bn) in 2014; +14.3% inlocal currency terms and +13.3% in US dollar terms. Forecast remains unchanged from Q313.



More Prescription Drugs reports by Business Monitor International

Sweden Pharmaceuticals and Healthcare Report Q1 2015 by Business Monitor International
Sweden Pharmaceuticals and Healthcare Report Q1 2015BMI View: Declining government reimbursement for prescription medicines does not bode well forinnovative drugmakers selling their products in Sweden, ...
Pakistan Pharmaceuticals and Healthcare Report Q1 2015 by Business Monitor International
Pakistan Pharmaceuticals and Healthcare Report Q1 2015BMI View: Pakistan holds great potential for pharmaceutical and healthcare companies, with the world'ssixth largest population. However, poor medical ...
Nigeria Pharmaceuticals and Healthcare Report Q1 2015 by Business Monitor International
Nigeria Pharmaceuticals and Healthcare Report Q1 2015BMI View: The Nigerian government remains committed to improving healthcare quality andinfrastructure across the country. The formation of the ...
New Zealand Pharmaceuticals and Healthcare Report Q1 2015 by Business Monitor International
New Zealand Pharmaceuticals and Healthcare Report Q1 2015BMI View: With New Zealand's population ageing rapidly, underlying demand for health services andpharmaceuticals is high for the ...
See all reports like this >>

More China Prescription Drugs reports

Pediatric Drugs Markets in China by Asia Market Information & Development Company
Pediatric Drugs Markets in ChinaChina's demand for Pediatric Drugs has grown at a fast pace in the past decade. In the next decade, both production ...
Antibiotics Markets in China by Asia Market Information & Development Company
Antibiotics Markets in ChinaChina's demand for Antibiotics has grown at a fast pace in the past decade. In the next decade, both production and demand ...
Prescription Drugs Markets in China by Asia Market Information & Development Company
Prescription Drugs Markets in ChinaChina's demand for Prescription Drugs has grown at a fast pace in the past decade. In the next decade, both production ...
China Pharmaceutical Mfg. Industry Data Report by Beijing Zeefer Consulting Ltd.
China Pharmaceutical Mfg. Industry Data ReportThis data report provides key statistics and concise analysis on pharmaceutical mfg. industry in China. It presents an overview on ...
See all reports like this >>

 

SELECT A LICENSE

    Report with 3 quarterly updates  USD 1,295  
    Report with 3 quarterly updates
3 User License
  USD 1,945  
    Report with 3 quarterly updates
5 User License
  USD 2,500  
    Report with 3 quarterly updates
Departmental/Site License
  USD 2,995  
    Global Site License Fulfilled by Publisher  USD 6,995  
 
US: 800.298.5699
Int'l: +1.240.747.3093
 

Share this report


    Other tasks

     
     
    Join Alert Me now!
    Receive bi-weekly email alerts on new market research

    Sign up today!